Predictive Value of HbA1c and Metabolic Syndrome for Renal Outcome in Non-Diabetic CKD Stage 1–4 Patients

Predictive Value of HbA1c and Metabolic Syndrome for Renal Outcome in Non-Diabetic CKD Stage 1–4 Patients

Glycated hemoglobin (HbA1c) levels are commonly used to indicate long-term glycemic control. An HbA1c level of 6.5–5.7% is defined as pre-diabetes and is proposed as a criterion for diagnosing metabolic syndrome (MetS). However, HbA1c levels can be affected by chronic kidney disease (CKD). Whether H...

Full description

Bibliographic Details
Main Authors: Chi-Chih Hung, Yen-Yi Zhen, Sheng-Wen Niu, Kun-Der Lin, Hugo You-Hsien Lin, Jia-Jung Lee, Jer-Ming Chang, I-Ching Kuo
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Biomedicines
Subjects:
HbA1c
metabolic syndrome
chronic kidney disease
Online Access:https://www.mdpi.com/2227-9059/10/8/1858

Internet

https://www.mdpi.com/2227-9059/10/8/1858

Similar Items